135 related articles for article (PubMed ID: 37438856)
1. Children's Oncology Group's 2023 blueprint for research: Young investigators.
Esbenshade AJ; Kahalley LS; Wistinghausen B; Cash T; Baertschiger RM; Zarnegar-Lumley S; Green A; Dhall G;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30567. PubMed ID: 37438856
[TBL] [Abstract][Full Text] [Related]
2. Long-term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology Group.
Esbenshade AJ; Pierson CR; Thompson AL; Reed D; Gupta A; Levy A; Kahalley LS; Harker-Murray P; Schore R; Muscal JA; Embry L; Maloney K; Horton T; Zweidler-Mckay P; Dhall G
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29193588
[TBL] [Abstract][Full Text] [Related]
3. Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group.
Esbenshade AJ; Kahalley LS; Baertschiger R; Dasgupta R; Goldsmith KC; Nathan PC; Harker-Murray P; Kitko CL; Kolb EA; Murphy ES; Muscal JA; Pierson CR; Reed D; Schore R; Unguru Y; Venkatramani R; Wistinghausen B; Dhall G
Pediatr Blood Cancer; 2019 Oct; 66(10):e27920. PubMed ID: 31309744
[TBL] [Abstract][Full Text] [Related]
4. How to be successful in an academic interview in pediatric oncology: A survey of Children's Oncology Group (COG) and International Society of Paediatric Oncology (SIOP) mentors.
Bryan G; Morgan JE; Dhall G; Esbenshade AJ
Pediatr Blood Cancer; 2021 Mar; 68(3):e28855. PubMed ID: 33356006
[TBL] [Abstract][Full Text] [Related]
5. Children's Oncology Group's 2023 blueprint for research: Diversity and health disparities.
Winestone LE; Beauchemin MP; Bona K; Kahn J; Prasad P; Robles JM; Velez MC;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30592. PubMed ID: 37501542
[TBL] [Abstract][Full Text] [Related]
6. Mentoring in pediatric oncology: a report from the Children's Oncology Group Young Investigator Committee.
Levy AS; Pyke-Grimm KA; Lee DA; Palla SL; Naranjo A; Saulnier Sholler G; Gratias E; Maloney K; Parshankar F; Lee-Scott M; Beierle EA; Gow K; Kim GE; Hunger S; Smith FO; Horton TM
J Pediatr Hematol Oncol; 2013 Aug; 35(6):456-61. PubMed ID: 23892351
[TBL] [Abstract][Full Text] [Related]
7. Children's Oncology Group's 2023 blueprint for research: Pharmacy.
Ostrenga AR; Thackray J; McLearan HH; Mulieri KM; Bisaccia E; Militano O; Dupuis LL; Bernhardt MB;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30581. PubMed ID: 37460409
[TBL] [Abstract][Full Text] [Related]
8. Children's Oncology Group's 2023 blueprint for research: Epidemiology.
Lupo PJ; Marcotte EL; Scheurer ME; Poynter JN; Spector LG;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30566. PubMed ID: 37449937
[TBL] [Abstract][Full Text] [Related]
9. Children's Oncology Group 2023 blueprint: Nursing discipline.
Zupanec S; Herriage T; Landier W;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30575. PubMed ID: 37470719
[TBL] [Abstract][Full Text] [Related]
10. Children's Oncology Group's 2023 blueprint for research: Rare tumors.
Schultz KAP; Chintagumpala M; Piao J; Chen KS; Gartrell R; Christison-Lagay E; Berry JL; Shah R; Laetsch TW;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30574. PubMed ID: 37458616
[TBL] [Abstract][Full Text] [Related]
11. Children's Oncology Group's 2023 blueprint for research: Behavioral science.
Embry L; Bingen K; Conklin HM; Hardy S; Jacola LM; Marchak JG; Paltin I; Pelletier W; Devine KA
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30557. PubMed ID: 37430416
[TBL] [Abstract][Full Text] [Related]
12. Children's Oncology Group's 2013 blueprint for research: adolescent and young adult oncology.
Freyer DR; Felgenhauer J; Perentesis J;
Pediatr Blood Cancer; 2013 Jun; 60(6):1055-8. PubMed ID: 23424167
[TBL] [Abstract][Full Text] [Related]
13. Children's Oncology Group's 2023 blueprint for research: Cancer control and supportive care.
Esbenshade AJ; Sung L; Brackett J; Dupuis LL; Fisher BT; Grimes A; Miller TP; Ullrich NJ; Dvorak CC;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30568. PubMed ID: 37430431
[TBL] [Abstract][Full Text] [Related]
14. Children's Oncology Group's 2023 blueprint for research: Developmental therapeutics.
Fox E; Parsons DW; Weigel BJ;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30563. PubMed ID: 37430453
[TBL] [Abstract][Full Text] [Related]
15. The Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network: A New Model for Addressing Site-Level Factors Impacting Clinical Trial Enrollment.
Roth M; Mittal N; Saha A; Freyer DR
J Adolesc Young Adult Oncol; 2020 Aug; 9(4):522-527. PubMed ID: 32077782
[No Abstract] [Full Text] [Related]
16. Children's Oncology Group's 2023 blueprint for research: Radiation oncology.
Kalapurakal JA; Wolden SL; Haas-Kogan D; Laack NN; Hua CH; Paulino AC; Hill-Kayser CE; Hoppe BS; Fitzgerald TJ;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30593. PubMed ID: 37486145
[TBL] [Abstract][Full Text] [Related]
17. Children's Oncology Group's 2023 blueprint for research: Neuroblastoma.
Bagatell R; DuBois SG; Naranjo A; Belle J; Goldsmith KC; Park JR; Irwin MS;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30572. PubMed ID: 37458162
[TBL] [Abstract][Full Text] [Related]
18. Children's Oncology Group's 2023 blueprint for research.
Hawkins DS; Gore L
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30569. PubMed ID: 37433635
[No Abstract] [Full Text] [Related]
19. A Tri-Institutional Approach to Address Disparities in Children's Oncology Group Clinical Trial Accrual for Adolescents and Young Adults and Underrepresented Minorities.
Mittal N; Davidson J; Martinez MF; Sanchez R; Sane N; Giordano L; Choi DK; Kent P; Dighe D; Iqbal A; Kiely C; Breen K; Quigley JG; Catchatourian R; Gitelis S; Schmidt ML
J Adolesc Young Adult Oncol; 2019 Jun; 8(3):227-235. PubMed ID: 30676208
[No Abstract] [Full Text] [Related]
20. Design and Success of a 21st Century Cancer Education Program at the University of Louisville.
Hein DW; Kidd CR
J Cancer Educ; 2018 Apr; 33(2):298-308. PubMed ID: 27474114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
